Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.

Journal Article

The Cancer Risk Intake System (CRIS), a computerized program that "matches" objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.

Full Text

Duke Authors

Cited Authors

  • Skinner, CS; Rawl, SM; Moser, BK; Buchanan, AH; Scott, LL; Champion, VL; Schildkraut, JM; Parmigiani, G; Clark, S; Lobach, DF; Bastian, LA

Published Date

  • April 2005

Published In

Volume / Issue

  • 20 / 4

Start / End Page

  • 360 - 365

PubMed ID

  • 15857495

Electronic International Standard Serial Number (EISSN)

  • 1525-1497

Digital Object Identifier (DOI)

  • 10.1111/j.1525-1497.2005.40115.x

Language

  • eng

Conference Location

  • United States